<DOC>
	<DOCNO>NCT01584505</DOCNO>
	<brief_summary>Cardiac Safety Study</brief_summary>
	<brief_title>Phase II Study Evaluate Cardiac Safety 2 Doses CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID Patients With Moderate Severe COPD</brief_title>
	<detailed_description>The purpose study demonstrate equivalence CHF1535 plus CHF5992 ( two different dosage ) CHF1535 alone change baseline average 24-hour heart rate , primary end point , ECG parameter .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Male female adult ≥ 40years ≤ 80years old 2 . Male subject : and/or partner must willing use approve method contraception 1 ) time dose administration 30 day last dose study . Subjects must donate sperm 30 day last dose study drug 3 . Written inform consent obtain patient prior study related procedure 4 . Outpatient diagnosis COPD ( define GOLD guideline , date 2010 ) least 6 month screen visit , include : Smoking history least 10 pack year define [ ( number cigarette smoke per day ) x ( number year smoke ) ] /20 ; current ex smoker eligible . For patient smoke cessation therapy must complete least 1 week study enrollment Regular use bronchodilator ( e.g . β2agonist or/and anticholinergic ) previous 2 month Visit 0 Postbronchodilator FEV1 ≥ 30 % ≤ 60 % predict normal value Postbronchodilator FEV1/FVC ≤ 0.70 1 . Pregnant lactate woman woman physiologically capable become pregnant UNLESS meet follow definition postmenopausal : 12 month natural ( spontaneous ) amenorrhea 6 month spontaneous amenorrhea already document serum FSH level &gt; 40mlU/mL use one follow acceptable method contraception Surgical sterilization ( e.g . bilateral tubal ligation , hysterectomy ) Hormonal contraception ( implantable , patch , oral ) Doublebarrier method ( double combination : IUD , male female condom spermicidal gel , diaphragm , sponge , cervical cap ) Reliable contraception maintain throughout study 30 day study drug discontinuation 2 . Current diagnosis asthma respiratory disorder ( COPD ) may interfere data interpretation accord investigator 's opinion 3 . Hospitalization due COPD exacerbation three month prior screen runin period COPD exacerbation require systemic steroid antibiotic 6 week prior screen runin period . COPD exacerbation define accord follow criterion : sustain worsen patient condition ( dyspnoea , cough and/or sputum production/purulence ) , stable state beyond normal daytoday variation , acute onset necessitates change regular medication include prescription oral corticosteroid and/or antibiotic , need hospitalization . 4 . Patient COPD require regular long term use oxygen therapy 5 . Patient require chronic mechanical ventilation COPD 6 . Patient treat regularly oral parenteral corticosteroid COPD 7 . Change COPD regular medication 4 week prior enrollment 8 . Unstable CV diseases 9 . Known abnormality cardiac valve</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>COPD</keyword>
</DOC>